- Report
- February 2024
- 175 Pages
Global
From €4962EUR$5,000USD£4,117GBP
- Report
- December 2024
- 164 Pages
Global
From €5408EUR$5,450USD£4,487GBP
- Report
- July 2024
- 142 Pages
Global
From €2976EUR$2,999USD£2,469GBP
- Report
- January 2024
- 200 Pages
Global
From €4118EUR$4,150USD£3,417GBP
- Report
- July 2024
- 164 Pages
Global
From €2481EUR$2,500USD£2,058GBP
- Report
- July 2024
- 121 Pages
North America
From €2976EUR$2,999USD£2,469GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1588EUR$1,600USD£1,317GBP
€1985EUR$2,000USD£1,647GBP
- Report
- July 2024
- 162 Pages
Africa
From €2481EUR$2,500USD£2,058GBP
- Report
- July 2024
- 288 Pages
Global
From €5426EUR$5,660USD£4,350GBP
- Report
- October 2024
- 192 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- October 2024
- 190 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- October 2024
- 192 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- October 2024
- 192 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- October 2024
- 195 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- November 2024
- 120 Pages
Global
From €5904EUR$5,950USD£4,899GBP
- Report
- October 2024
- 198 Pages
Global
From €3518EUR$3,545USD£2,919GBP
€3909EUR$3,939USD£3,243GBP
- Report
- March 2024
- 118 Pages
Global
From €4465EUR$4,500USD£3,705GBP
- Report
- May 2024
- 134 Pages
Global
From €6449EUR$6,499USD£5,351GBP
- Report
- June 2024
- 200 Pages
Global
From €6311EUR$6,360USD£5,236GBP
€7889EUR$7,950USD£6,545GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1588EUR$1,600USD£1,317GBP
€1985EUR$2,000USD£1,647GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more